Pemirolast Market Share 2020 | Growth Projection, Future Key Insights, Sales Estimations, Size Analysis, Upcoming Trends and Business Overview By 2027

Pemirolast is a mast cell stabilizer, which acts as an anti-allergic agent. Pemirolast treats allergic reactions by preventing mast cell degranulation, which stabilizes the mast cell and inhibits the release of inflammatory mediators such as histamines and leukotriene.

The pemirolast potassium is a light yellow-colored ophthalmic aqueous sterile solution that is used to prevent allergic reactions such as itching in eyes, caused by hay fever, and allergic conjunctivitis. The pemirolast potassium inhibits the release of inflammatory mediators from the eosinophils in the ocular tissue. Pemirolast is also used to treat pulmonary conditions such as bronchial asthma and allergic rhinitis.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/3466

Global Pemirolast Market – Dynamics

Rising incidence of allergic conjunctivitis is expected to propel growth of the global pemirolast market over the forecast period. For instance, according to the article published in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology, in April 2019, simple allergic conjunctivitis affects around 10% to 30% of the population globally.

Moreover, adoption of inorganic growth strategies such as mergers, collaborations, and acquisitions by major players are expected to propel the market growth over the forecast period. For instance, in March 2017, Nipro Corporation, acquired the Tanabe Seiyaku Hanbai Co., Ltd., an alegysal (potassium pemirolast) manufacturing subsidiary of Mitsubishi Tanabe Pharma Corporation. The acquisition is expected to enhance Nipro’s offerings in the global generic drugs market, including alegysal.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3466

Global Pemirolast Market – Regional Insights

North America accounted for the largest market share in 2018, owing to high prevalence of allergic rhinitis (hay fever) in the region. For instance, according to the National Health Interview Survey, 2018, around 19.2 million adults and 5.2 million children were diagnosed with allergic rhinitis in the U.S. in 2017. Moreover, increasing prevalence of allergic eye disease in North America is expected to drive the global pemirolast market over the forecast period. For instance, according to the Allergy, Asthma & Clinical Immunology Journal, 2020, around 40% population of North America is affected by allergic eye disease.

Furthermore, increasing cases of pediatric asthma due to air pollution is expected to propel the pemirolast market growth in the Asia Pacific over the forecast period. For instance, according to the global study published by the National Center for Biotechnology Information (NCBI), in April 2019, pediatric asthma cases due to anthropogenic particulate matters in India, China, and Bangladesh were estimated to be around 57%, 51%, and 70%, respectively.

Global Pemirolast Market – Competitive Landscape

Key players operating in the global market include Santen Pharmaceutical Co., Ltd, Nipro Corporation, Clearsynth, Bristol-Myers Squibb Company, Toronto Research Chemicals Inc., Jiaxing Epochem Pharmtech Co., Ltd., LGM Pharma, Vistakon Pharmaceuticals LLC, and Aescu Pharma, Inc.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/pemirolast-market-3466

Global Pemirolast Market – Taxonomy

On the basis of dosage form, the global pemirolast market is segmented into:

• Eye Drops
• Tablets

On the basis of disease indication, the global pemirolast market is segmented into:

• Allergic Conjunctivitis
• Bronchial Asthma
• Allergic Rhinitis

On the basis of distribution channel, the global pemirolast market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

On the basis of region, the global pemirolast market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.